ABVC
Price
$2.59
Change
+$0.02 (+0.78%)
Updated
Dec 4, 10:53 AM (EDT)
Capitalization
63.18M
Intraday BUY SELL Signals
MDXXF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Capitalization
7M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABVC vs MDXXF

Header iconABVC vs MDXXF Comparison
Open Charts ABVC vs MDXXFBanner chart's image
ABVC BioPharma
Price$2.59
Change+$0.02 (+0.78%)
Volume$2K
Capitalization63.18M
PharmAla Biotech Holdings
Price$0.07
Change-$0.00 (-0.00%)
Volume$15.5K
Capitalization7M
ABVC vs MDXXF Comparison Chart in %
ABVC
Daily Signal:
Gain/Loss:
MDXXF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABVC vs. MDXXF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and MDXXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ABVC: $2.55 vs. MDXXF: $0.07)
Brand notoriety: ABVC and MDXXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 31% vs. MDXXF: 15%
Market capitalization -- ABVC: $63.18M vs. MDXXF: $7M
ABVC [@Biotechnology] is valued at $63.18M. MDXXF’s [@Biotechnology] market capitalization is $7M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileMDXXF’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • MDXXF’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than MDXXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 3 TA indicator(s) are bullish while MDXXF’s TA Score has 2 bullish TA indicator(s).

  • ABVC’s TA Score: 3 bullish, 5 bearish.
  • MDXXF’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ABVC is a better buy in the short-term than MDXXF.

Price Growth

ABVC (@Biotechnology) experienced а -0.78% price change this week, while MDXXF (@Biotechnology) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVC($63.2M) has a higher market cap than MDXXF($7M). ABVC YTD gains are higher at: 332.203 vs. MDXXF (-58.893). MDXXF has higher annual earnings (EBITDA): -1.86M vs. ABVC (-3.57M). MDXXF has more cash in the bank: 1.25M vs. ABVC (453K). MDXXF has higher revenues than ABVC: MDXXF (421K) vs ABVC (391K).
ABVCMDXXFABVC / MDXXF
Capitalization63.2M7M903%
EBITDA-3.57M-1.86M192%
Gain YTD332.203-58.893-564%
P/E RatioN/AN/A-
Revenue391K421K93%
Total Cash453K1.25M36%
Total Debt1.59MN/A-
FUNDAMENTALS RATINGS
ABVC: Fundamental Ratings
ABVC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVCMDXXF
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
87%
Momentum
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 7 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signal:
Gain/Loss:
MDXXF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BATRB56.00N/A
N/A
Atlanta Braves Holdings, Inc.
DAIUF31.67N/A
N/A
Daifuku Co., Ltd.
QNTO10.25N/A
N/A
Quaint Oak Bancorp, Inc.
EBGEF24.66N/A
N/A
Enbridge Inc.
MMILF0.05N/A
N/A
Metro Mining Ltd.

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-2.30%
KNSA - ABVC
40%
Loosely correlated
-2.06%
MRSN - ABVC
33%
Loosely correlated
+0.29%
MLEC - ABVC
31%
Poorly correlated
+15.52%
FULC - ABVC
27%
Poorly correlated
-9.27%
MDXXF - ABVC
25%
Poorly correlated
N/A
More

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
N/A
NICXF - MDXXF
46%
Loosely correlated
N/A
ABVC - MDXXF
25%
Poorly correlated
-2.30%
ZIVO - MDXXF
23%
Poorly correlated
N/A
KNSA - MDXXF
20%
Poorly correlated
-2.06%
VYGR - MDXXF
20%
Poorly correlated
-4.89%
More